Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular Pharmacology

• Publication date

  2004-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/MOL.65.6.1336PMID 15155827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo

  2004cited by this paper
• Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors

  2004cited by this paper
• Multidimensional QSAR: Moving from three‐ to five‐dimensional concepts

  2002influential reference
• Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation

  2002cited by this paper
• 5D-QSAR: the key for simulating induced fit?

  2002influential reference
• Chemoproteomics as a basis for post-genomic drug discovery.

  2002cited by this paper
• Structural constraints affect the metabolism of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) by carboxylesterases.

  2001cited by this paper
• Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda, and COS7 cells for recombinant gene expression

  2000cited by this paper
• Fast prediction and visualization of protein binding pockets with PASS

  2000cited by this paper
• Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method

  2000cited by this paper
• Proficient metabolism of irinotecan by a human intestinal carboxylesterase.

  2000cited by this paper
• Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.

  1999cited by this paper
• Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children.

  1999cited by this paper
• Design and therapeutic application of matrix metalloproteinase inhibitors.

  1999cited by this paper
• Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy.

  1999cited by this paper
• Bioactive Diversity and Screening Library Selection via Affinity Fingerprinting

  1998influential reference
• Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase.

  1998cited by this paper
• Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11).

  1998cited by this paper
• Efficacy of systemic administration of irinotecan against neuroblastoma xenografts.

  1997cited by this paper
• Efficacy of oral irinotecan against neuroblastoma xenografts.

  1997cited by this paper
• St. Jude Children's Research Hospital.

  1997cited by this paper
• Raster3D: photorealistic molecular graphics.

  1997cited by this paper
• Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.

  1997cited by this paper
• Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver.

  1997cited by this paper
• Synthesis of CPT‐11 (Irinotecan Hydrochloride Trihydrate)

  1996cited by this paper
• Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.

  1996cited by this paper
• Predicting ligand binding to proteins by affinity fingerprinting.

  1995cited by this paper
• Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials.

  1994cited by this paper
• Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase.

  1994cited by this paper
• Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.

  1992cited by this paper
• A program to produce both detailed and schematic plots of protein structures

  1991cited by this paper
• A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases.

  1991cited by this paper
• Microtiter assay for acetylcholinesterase.

  1987cited by this paper
• Analytical Study of Microsomes and Isolated Subcellular Membranes from Rat Liver I. Biochemical Methods

  1974influential reference
• ANALYTICAL STUDY OF MICROSOMES AND ISOLATED SUBCELLULAR MEMBRANES FROM RAT LIVER

  1974cited by this paper
• ANALYTICAL STUDY OF MICROSOMES AND ISOLATED SUBCELLULAR MEMBRANES FROM RAT LIVER

  1974influential reference
• Enzyme and Metabolic Inhibitors. Volume I. General Principles of Inhibition.

  1964cited by this paper
• Enzyme and metabolic inhibitors

  1963cited by this paper
• General principles of inhibition

  1963cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Discovery of orally active and serine-targeting covalent inhibitors against hCES2A for ameliorating irinotecan-triggered gut toxicity

  2025cites this paper
• Discovery of cardiovascular drugs as effective inhibitors of human carboxylesterase.

  2025cites this paper
• Discovery of a Novel Serine-Targeting Covalent Inhibitor against HCES2A for Treating Drug-induced Diarrhea and Ulcerative Colitis.

  2025cites this paper
• Influence of the sulfonyl group on the biological activity of 2-sulfonarylhydrazinylidene 1,3-dicarbonyl compounds

  2024cites this paper
• Directionally Modified Fluorophores for Super-Resolution Imaging of Target Enzymes: A Case Study with Carboxylesterases.

  2021cites this paper
• Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold.

  2021cites this paper
• Epicatechin gallate and epigallocatechin gallate are potent inhibitors of human arylacetamide deacetylase.

  2021cites this paper
• QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping

  2020cites this paper
• The role of carboxylesterase enzymes in capecitabine therapy

  2020cites this paper
• Discovery of natural alkaloids as potent and selective inhibitors against human carboxylesterase 2.

  2020cites this paper
• Demethylbellidifolin isolated from Swertia bimaculate against human carboxylesterase 2: Kinetics and interaction mechanism merged with docking simulations.

  2019cites this paper
• Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes

  2019cites this paper
• Catalyst-free visible-light-induced condensation to synthesize bis(indolyl)methanes and biological activity evaluation of them as potent human carboxylesterase 2 inhibitors

  2019cites this paper
• Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.

  2019cites this paper
• Oncolytic viruses , Vaccinia virus , Carboxylesterase 2 , Interferon beta 1 , Irinotecan Ac ce pt ed A rti cle

  2019cites this paper
• Evaluation of 4-phenylamino-substituted naphthalene-1,2-diones as tubulin polymerization inhibitors.

  2018cites this paper
• Human carboxylesterases: a comprehensive review

  2018cites this paper
• Facile synthesis of 1,2-dione-containing abietane analogues for the generation of human carboxylesterase inhibitors.

  2018cites this paper
• Potent, Irreversible Inhibition of Human Carboxylesterases by Tanshinone Anhydrides Isolated from Salvia miltiorrhiza ("Danshen").

  2018cites this paper
• Characterization and structure-activity relationship studies of flavonoids as inhibitors against human carboxylesterase 2.

  2018cites this paper
• Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity

  2017cites this paper
• Recent progress in the discovery of natural inhibitors against human carboxylesterases.

  2017cites this paper
• Selective Inhibitors of Human Liver Carboxylesterase Based on a β-Lapachone Scaffold: Novel Reagents for Reaction Profiling.

  2017cites this paper
• Modeling Polypharmacological Profiles by Affinity Fingerprinting.

  2017cites this paper
• Comparative metabolism of DDAO benzoate in liver microsomes from various species.

  2017cites this paper
• Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.

  2016cites this paper
• Regulations of Xenobiotics and Endobiotics on Carboxylesterases: A Comprehensive Review

  2016cites this paper
• Carboxylesterases: General detoxifying enzymes.

  2016cites this paper
• Identification and characterization of naturally occurring inhibitors against human carboxylesterase 2 in White Mulberry Root-bark.

  2016cites this paper
• Highly sensitive and selective detection of human carboxylesterase 1 activity by liquid chromatography with fluorescence detection.

  2016cites this paper
• Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance

  2016cites this paper
• A highly selective fluorescent ESIPT probe for the detection of Human carboxylesterase 2 and its biological applications.

  2015cites this paper
• Fructus Psoraleae contains natural compounds with potent inhibitory effects towards human carboxylesterase 2.

  2015cites this paper
• A ratiometric fluorescent sensor for highly selective detection of human carboxylesterase 2 and its application in living cells

  2014cites this paper
• Screening of Specific Inhibitors for Human Carboxylesterases or Arylacetamide Deacetylase

  2014cites this paper
• Screening of Specific Inhibitors for Human Carboxylesterases or Arylacetamide Deacetylase

  2014cites this paper
• Old Drug New Use—Amoxapine and Its Metabolites as Potent Bacterial β-Glucuronidase Inhibitors for Alleviating Cancer Drug Toxicity

  2014cites this paper
• Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11)

  2013cites this paper
• Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.

  2013cites this paper
• Inhibition of porcine liver carboxylesterase by phosphorylated flavonoids.

  2013cites this paper
• Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors.

  2013cites this paper
• Évaluation du terrain génétique des hypersensibilités

  2013cites this paper
• Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").

  2013cites this paper
• Predicting hiCE inhibitors based upon pharmacophore models derived from the receptor and its ligands

  2013cites this paper
• Global and local molecular dynamics of a bacterial carboxylesterase provide insight into its catalytic mechanism

  2012cites this paper
• Synthesis and biological activity of O-carbamoylated 1,1,1,3,3,3-hexafluoroisopropanols as new specific inhibitors of carboxylesterase

  2012cites this paper
• Improved superaugmented eccentric connectivity indices

  2012cites this paper
• Mechanisms of Drug Metabolism

  2012cites this paper
• Accurate determination of the anticancer prodrug simmitecan and its active metabolite chimmitecan in various plasma samples based on immediate deactivation of blood carboxylesterases.

  2011cites this paper
• Carboxylesterase inhibitors

  2011cites this paper
• Purification and Biochemical Characterization of N-methyl-Histidylesterase from Camel （Camelus dromedarius） Liver

  2011cites this paper
• Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones.

  2011cites this paper
• Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11.

  2011cites this paper
• Molecular details of the catalytic activity of carboxylesterases

  2011cites this paper
• Biochemical and molecular analysis of carboxylesterase‐mediated hydrolysis of cocaine and heroin

  2010cites this paper
• The Role of Drug Metabolism in Toxicity

  2010cites this paper
• Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids.

  2010cites this paper
• In Silico Design and Evaluation of Carboxylesterase Inhibitors.

  2010cites this paper
• Structure-activity relationships of substituted 1-pyridyl-2-phenyl-1,2-ethanediones: potent, selective carboxylesterase inhibitors.

  2010cites this paper
• Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity.

  2009cites this paper
• Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis.

  2009cites this paper
• Irinotecan side effects relieved by the use of HI-6 oxime: in vivo experimental approach.

  2009cites this paper
• Identification of human intestinal carboxylesterase as the primary enzyme for activation of a doxazolidine carbamate prodrug.

  2008cites this paper
• Applications of carboxylesterase activity in environmental monitoring and toxicity identification evaluations (TIEs).

  2008cites this paper
• Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.

  2007cites this paper
• Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils.

  2007cites this paper
• Methods for predicting human drug metabolism.

  2007cites this paper
• Irinotecan‐induced Diarrhea: Functional Significance of the Polymorphic ABCC2 Transporter Protein

  2007cites this paper
• Evaluation of HI-6 oxime: potential use in protection of human acetylcholinesterase inhibited by antineoplastic drug irinotecan and its cyto/genotoxicity in vitro.

  2007cites this paper
• Hypoxia‐targeted over‐expression of carboxylesterase as a means of increasing tumour sensitivity to irinotecan (CPT‐11)

  2007cites this paper
• Principles of Drug Metabolism 3: Enzymes and Tissues

  2007cites this paper
• Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.

  2007cites this paper
• Analysis of Mammalian Carboxylesterase Inhibition by Trifluoromethylketone-Containing Compounds

  2007cites this paper
• Prodrugs: Absorption, Distribution, Metabolism, Excretion (ADME) Issues

  2007cites this paper
• Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.

  2007cites this paper
• Étude du transporteur de multiples drogues MRP1 : caractérisation des NBD, et étude de modulateurs conduisant à la mort des cellules surexprimant le transporteur

  2007cites this paper
• Esterase Inhibition by Grapefruit Juice Flavonoids Leading to a New Drug Interaction

  2007cites this paper
• Intestinal tract injury by drugs: Importance of metabolite delivery by yellow bile road.

  2006cites this paper
• A Roadmap to Individualized Irinotecan Dosing

  2006cites this paper
• Intestinal microflora and digestive toxicity of irinotecan in mice.

  2006cites this paper
• Hepatic transport, Metabolism and biliary excretion of irinotecan in a cancer patient with an external bile drain

  2006cites this paper
• Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors.

  2006cites this paper
• Prevention of irinotecan associated diarrhea by intestinal alkalization. A pilot study in gastrointestinal cancer patients

  2006cites this paper
• The role of intestinal UDP-glucuronosyltransferases in 7-ethyl-10-hydroxy-camptothecin (SN-38) conjugation and toxicity

  2006cites this paper
• Enzymes involved in the bioconversion of ester-based prodrugs.

  2006cites this paper
• Role of ABCG2/BCRP in biology and medicine.

  2006cites this paper
• Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

  2006cites this paper
• Prevention of irinotecan associated diarrhea by intestinal alkalization. A pilot study in gastrointestinal cancer patients.

  2006cites this paper
• Carboxylesterases--detoxifying enzymes and targets for drug therapy.

  2006cites this paper
• Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicity

  2006cites this paper
• IntestinalMicroflora and Digestive Toxicity of Irinotecan inMice

  2006cites this paper
• Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases.

  2006cites this paper
• Target-related affinity profiling: Telik's lead discovery technology.

  2005cites this paper
• Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11.

  2005cites this paper
• Overview of Carboxylesterases and Their Role in the Metabolism of Insecticides

  2005cites this paper
• Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil.

  2005cites this paper
• Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases.

  2005cites this paper
• Novel agents that potentially inhibit irinotecan-induced diarrhea.

  2005cites this paper
• Inhibition of carboxylesterases by benzil (diphenylethane-1,2-dione) and heterocyclic analogues is dependent upon the aromaticity of the ring and the flexibility of the dione moiety.

  2005cites this paper
• Mammalian carboxylesterases: from drug targets to protein therapeutics.

  2005cites this paper